Work

1020P MPT-0118 a clinical drug candidate to assess Treg reprogramming via MALT1 blockade

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1404

Authors: P. Keller, I. Mazo, Y. Gao, V. Reddy, F. Caballero, B. Stephens, J.E. Marvin, A. Fu, Y. Sun, R.W. Jenkins, U.H. von Andrian, T.R. Mempel

Institutions: University of Utah, Massachusetts General Hospital, Harvard University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3203279895

FWCI: 0.183

Cites:

Cited by: 2

Related to: 10